Company
株式会社MOLCURE
Accelerating Drug Discovery with AI-Driven Molecular Design
- Status
- Operatingas of 2026-09-22
- Business model
- B2B
- Founded
- 2013
- Customers
- pharmaceutical partners
- Legal name
- MOLCURE Inc.
- molcure.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
MOLCURE combines proprietary large language models, physics-based simulations, and high-quality experimental data from our in-house biolab to discover effective biotherapeutics against challenging targets.
Products
- Other
- AI Antibody Discovery Platform
- Web
- AI Antibody Discovery Platform
Loading relationship preview